Earnings calls
Aurobindo Pharma earnings calls
9 calls on file, latest transcript filed 11 Nov 2026. Each page lists what the company said on the call, with the transcript sentence it came from.
By DalalOS Data Desk. Assembled by software from the company's transcript. Not reviewed by a person.
| QUARTER | TRANSCRIPT FILED | QUESTIONS AND ANSWERS |
|---|---|---|
| Q2 FY27 call | 11 Nov 2026 | Not separated in this transcript |
| Q1 FY27 call | 13 Aug 2026 | Not separated in this transcript |
| Q4 FY26 call | 27 May 2026 | 52 answers |
| Q3 FY26 call | 16 Feb 2026 | 54 answers |
| Q2 FY26 call | 11 Nov 2025 | 47 answers |
| Q1 FY26 call | 8 Aug 2025 | 56 answers |
| Q4 FY25 call | 2 Jun 2025 | 44 answers |
| Q3 FY25 call | 13 Feb 2025 | 47 answers |
| Q2 FY25 call | 18 Nov 2024 | 54 answers |
Aurobindo Pharma: price, results and ownership
What the company said on its earnings call, taken from its own transcript. Not advice. Research and analysis only, not investment advice.